Fibroblast Growth Factor-23 and Risks of Cardiovascular and Noncardiovascular Diseases: A Meta-Analysis

Background Fibroblast growth factor-23 (FGF-23) has been hypothesized to play a role in the increased risk of cardiovascular disease in patients with CKD. Methods We identified prospective studies reporting associations between FGF-23 concentration and risk of cardiovascular events. Maximally adjust...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Am Soc Nephrol
Main Authors: Marthi, Amarnath, Donovan, Killian, Haynes, Richard, Wheeler, David C., Baigent, Colin, Rooney, Christopher M., Landray, Martin J., Moe, Sharon M., Yang, Jun, Holland, Lisa, di Giuseppe, Romina, Bouma-de Krijger, Annet, Mihaylova, Borislava, Herrington, William G.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Nephrology 2018
Assuntos:
Meta-Analysis
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6050929/
https://ncbi.nlm.nih.gov/pubmed/29764921
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2017121334
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados